
Begberon S 25mg/5mg Tablet ER
Marketer
Leeford Healthcare Ltd
Salt Composition
Mirabegron (25mg) + Solifenacin (5mg)
Overview Begberon S 25mg/5mg Tablet ER
Urovesa 25mg/5mg Extended-Release Tablets combine two active ingredients to manage overactive bladder symptoms. This medication provides relief from frequent urination, urgency, and incontinence. Always follow your physician's instructions regarding dosage and treatment duration. Urovesa may be taken with or without food, ideally at the same time daily. Discontinuing the medication prematurely without consulting your doctor may exacerbate symptoms; complete the prescribed course for optimal results. Commonly reported side effects include elevated blood pressure, inflammation of the nose and throat (nasopharyngitis), urinary tract infections, and headaches. Report any concerning or persistent side effects to your doctor immediately. Prior to starting treatment, disclose all other medications, including those for pre-existing conditions, to your doctor. Pregnant or breastfeeding individuals should inform their physician before commencing treatment. Patients with liver or kidney impairment require careful monitoring and regular checkups as directed by their doctor.
Primary Ingredients of Begberon S 25mg/5mg Tablet ER
No text provided. Please provide the text you wish me to rephrase.
Uses of Begberon S 25mg/5mg Tablet ER
Symptoms of an overactive bladder
Major Benefits of Begberon S 25mg/5mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Begberon S 25mg/5mg Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While this medication can be administered with or without food, consistent timing is recommended for optimal results.
Common Side effects of Begberon S 25mg/5mg Tablet ER:
- High blood pressure
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Dryness in mouth
- Constipation
- Increased heart rate
- Blurred vision
How to use Begberon S 25mg/5mg Tablet ER:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Begberon S 25mg/5mg Tablet ER whole; avoid chewing, crushing, or breaking it. This extended-release tablet can be administered with or without food, although consistent timing is recommended.
How Begberon S 25mg/5mg Tablet ER works:
Begberon S 25mg/5mg Extended-Release tablets contain Mirabegron and Solifenacin, two medications that synergistically alleviate urinary symptoms. Mirabegron, a beta-3 adrenergic agonist, promotes bladder muscle relaxation by stimulating specific bladder receptors. Solifenacin, an antimuscarinic agent, similarly reduces bladder muscle spasms. This combined action effectively reduces urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while taking Begberon S 25mg/5mg Extended-Release Tablets. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Begberon S 25mg/5mg Extended-Release tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Begberon S 25mg/5mg Tablet ER while breastfeeding is absent. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The impact of Begberon S 25mg/5mg Tablet ER on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Begberon S 25mg/5mg Tablet ER in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the use of Begberon S 25mg/5mg Extended-Release Tablets in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Begberon S 25mg/5mg Tablet ER :
NA
Facts to Know About Begberon S 25mg/5mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Urology |
